Topics
Glioblastoma | Treatment | Targeted therapy | Selinexor
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Selinexor
Mathen P, Chaudhry H, Mackey M, Cooley-Zgela T, Masciocchi M, Li
B, Huang E, Wu J, Smart D, Krauze A, Camphausen K.
Phase
I dose escalation of the Exportin 1 inhibitor, Selinexor, in
combination with chemoradiation in patients with newly diagnosed
glioblastoma.
medRxiv
[Preprint]. 2026 Jul 7:2026.06.25.26356263. doi:
10.64898/2026.06.25.26356263. PMID:
42465896. Trial
registration ID: NCT04216329.
ˍ